Medcomp Cited For Tesio Catheter QSR Deficiencies In FDA Warning Letter
This article was originally published in The Gray Sheet
Executive Summary
Medical Components' failures to thoroughly process complaints and conduct post-sterilization stress testing on its Tesio hemodialysis catheters are highlighted in a June 8 FDA warning letter citing the firm for quality system regulation violations.